Luciferase Immunoprecipitation Systems for Measuring Antibodies in Autoimmune and Infectious Diseases

Overview

Journal Transl Res

Publisher Elsevier

Specialty Pathology

Date 2014 Sep 23

PMID 25241936

Citations 44

Authors

Peter D Burbelo

Evan E Lebovitz

Abner L Notkins

Affiliations

Soon will be listed here.

Abstract

Antibody profiles have the potential to revolutionize personalized medicine by providing important information related to autoimmunity against self-proteins and exposure to infectious agents. One immunoassay technology, luciferase immunoprecipitation systems (LIPS), harnesses light-emitting recombinant proteins to generate robust, high-quality antibody data often spanning a large dynamic range of detection. Here, we describe the general format of LIPS and discuss studies using the technology to measure autoantibodies in several human autoimmune diseases including type 1 diabetes, Sjögren's syndrome, systemic lupus erythematosus, and immunodeficiencies secondary to anticytokine autoantibodies. We also describe the usefulness of evaluating antibodies against single or multiple antigens from infectious agents for diagnosis, pathogen discovery, and for obtaining individual exposure profiles. These diverse findings support the notion that the LIPS is a useful technology for generating antibody profiles for personalized diagnosis and monitoring of human health.

Citing Articles

Acquired Osteomalacia Associated with Autoantibodies against PHEX.

Hoshino Y, Okamoto K, Ogawa T, Kato H, Irie K, Watanabe S N Engl J Med. 2025; 392(5):513-515.

PMID: 39879599 PMC: 11781776. DOI: 10.1056/NEJMc2405746.

Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease.

Burbelo P, Huapaya J, Khavandgar Z, Beach M, Pinal-Fernandez I, Mammen A Front Immunol. 2024; 15:1462242.

PMID: 39524452 PMC: 11543486. DOI: 10.3389/fimmu.2024.1462242.

The Oncoprotein Fra-2 Drives the Activation of Human Endogenous Retrovirus Env Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) Patients.

Tram J, Marty L, Mourouvin C, Abrantes M, Jaafari I, Cesaire R Cells. 2024; 13(18.

PMID: 39329701 PMC: 11430398. DOI: 10.3390/cells13181517.

Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence survival.

Kuhn D, Heinen N, Sutter K, Herrmann S, Nocke M, Todt D J Med Virol. 2024; 96(10):e29935.

PMID: 39323094 PMC: 11535095. DOI: 10.1002/jmv.29935.

Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations.

Waters M, Hybiske K, Ikeda R, Kaltenboeck B, Manhart L, Kreisel K J Infect Dis. 2024; 230(1):250-262.

PMID: 39052727 PMC: 11272089. DOI: 10.1093/infdis/jiae199.

References

Kapoor A, Li L, Victoria J, Oderinde B, Mason C, Pandey P . Multiple novel astrovirus species in human stool. J Gen Virol. 2009; 90(Pt 12):2965-2972. PMC: 2796194. DOI: 10.1099/vir.0.014449-0. View

Burbelo P, Seam N, Groot S, Ching K, Han B, Meduri G . Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med. 2010; 8:97. PMC: 2970592. DOI: 10.1186/1479-5876-8-97. View

Burbelo P, Groot S, Dalakas M, Iadarola M . High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem Biophys Res Commun. 2007; 366(1):1-7. PMC: 2215321. DOI: 10.1016/j.bbrc.2007.11.077. View

Burbelo P, Kovacs J, Ching K, Issa A, Iadarola M, Murphy A . Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients. J Infect Dis. 2010; 202(6):894-8. PMC: 2924471. DOI: 10.1086/655780. View

Burbelo P, Issa A, Ching K, Cohen J, Iadarola M, Marques A . Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol. 2010; 17(6):904-9. PMC: 2884422. DOI: 10.1128/CVI.00476-09. View

Burbelo P, Meoli E, Leahy H, Graham J, Yao K, Oh U . Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology. 2008; 5:96. PMC: 2580768. DOI: 10.1186/1742-4690-5-96. View

Burbelo P, Bren K, Ching K, Gogineni E, Kottilil S, Cohen J . LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV. Mol Biosyst. 2011; 7(5):1453-62. PMC: 3430135. DOI: 10.1039/c0mb00342e. View

Mendoza D, Johnson S, Peterson B, Natarajan V, Salgado M, Dewar R . Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood. 2012; 119(20):4645-55. PMC: 3367872. DOI: 10.1182/blood-2011-10-381996. View

Burbelo P, Ching K, Klimavicz C, Iadarola M . Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp. 2009; (32). PMC: 3164068. DOI: 10.3791/1549. View

10.

Burbelo P, Ramanathan R, Klion A, Iadarola M, Nutman T . Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol. 2008; 46(7):2298-304. PMC: 2446928. DOI: 10.1128/JCM.00490-08. View

11.

Visscher P, Brown M, McCarthy M, Yang J . Five years of GWAS discovery. Am J Hum Genet. 2012; 90(1):7-24. PMC: 3257326. DOI: 10.1016/j.ajhg.2011.11.029. View

12.

Cohen J, Ali M, Bayat A, Steinberg S, Park H, Gershon A . Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay. Clin Vaccine Immunol. 2014; 21(9):1288-91. PMC: 4178563. DOI: 10.1128/CVI.00250-14. View

13.

Ramanathan R, Burbelo P, Groot S, Iadarola M, Neva F, Nutman T . A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis. 2008; 198(3):444-51. PMC: 3379004. DOI: 10.1086/589718. View

14.

Burbelo P, Hoshino Y, Leahy H, Krogmann T, Hornung R, Iadarola M . Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol. 2009; 16(3):366-71. PMC: 2650866. DOI: 10.1128/CVI.00350-08. View

15.

Enose-Akahata Y, Abrams A, Johnson K, Maloney E, Jacobson S . Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica. Blood. 2012; 119(12):2829-36. PMC: 3327461. DOI: 10.1182/blood-2011-11-390807. View

16.

Burbelo P, Ching K, Morse C, Alevizos I, Bayat A, Cohen J . Altered antibody profiles against common infectious agents in chronic disease. PLoS One. 2013; 8(12):e81635. PMC: 3847058. DOI: 10.1371/journal.pone.0081635. View

17.

Burbelo P, Ching K, Bren K, Iadarola M . Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics. 2011; 8(3):309-16. PMC: 3818131. DOI: 10.1586/epr.11.23. View

18.

Browne S, Burbelo P, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw P . Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012; 367(8):725-34. PMC: 4190026. DOI: 10.1056/NEJMoa1111160. View

19.

Burbelo P, Leahy H, Iadarola M, Nutman T . A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis. 2009; 3(5):e438. PMC: 2677158. DOI: 10.1371/journal.pntd.0000438. View

20.

Burbelo P, Ching K, Esper F, Iadarola M, Delwart E, Lipkin W . Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent. PLoS One. 2011; 6(8):e22576. PMC: 3150362. DOI: 10.1371/journal.pone.0022576. View